Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Breast Neoplasms 21Prostatic Neoplasms 17Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Neoplasms 7Neoplasm Metastasis 6Carcinoma, Transitional Cell 5Triple Negative Breast Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Salivary Gland Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Nasopharyngeal Carcinoma 3Melanoma 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Carcinoma 3Recurrence 2Osteosarcoma 2Non-Muscle Invasive Bladder Neoplasms 2Lymphoid Interstitial Pneumonia 2Laryngeal Neoplasms 2HER2-positive Breast Cancer 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2

Interventions

Radiotherapy 2Cisplatin 2niraparib 1monalizumab 1linrodostat 1durvalumab 1dostarlimab 1Surgical Flaps 1Nivolumab 1Fluorouracil 1Docetaxel 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Laryngeal Diseases × Docetaxel × Clear all
NCT03340896 2025-09-02

SALTORL

Groupe Oncologie Radiotherapie Tete et Cou

Phase 3 Active not recruiting
256 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡